Cancer BiologybioRxivPreprint
ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY APPROVED KIDROLASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS
A. Trinh, R. Khamari, Q. Fovez…·P. Marchetti
This study shows that combining tyrosine kinase inhibitors with Kidrolase targets glutamine metabolism and enhances CML stem cell eradication.
DOI 10.1101/2020.09.21.305714